Bacterial 16S rRNA V3-V4 Amplicon Sequencing & Analysis in UAE | 1,500 AED | DHA Licensed

Executive Summary & Core Metrics

Bacterial 16S rRNA V3-V4 amplicon sequencing delivers species-level microbial identification with 99.9% diagnostic sensitivity, processed under ISO 9001:2015 accredited workflows. The assay targets hypervariable regions V3 and V4 via Illumina MiSeq next-generation sequencing (PE300 chemistry) to provide comprehensive taxonomic profiling from whole blood or extracted DNA.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity confirmed via ISO 9001:2015 accredited pipeline.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test interpretation by a Consultant Medical Genetics specialist.
Insurance Verification: Direct billing confirmation via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This assay uses next-generation amplicon sequencing to profile bacterial communities by amplifying and sequencing the V3-V4 hypervariable regions of the 16S ribosomal RNA gene. The resulting data enables species-level identification, quantitative abundance estimation, and phylogenetic classification for clinical correlation with host symptoms or disease states.

Feature	Our Test (Amplicon Sequencing V3-V4)	Closest Alternative (Culture-Based or Sanger)
Precision	Species-level resolution via NGS	Often genus-level; many unculturable species missed
Method	Illumina MiSeq with PE300 chemistry	Phenotypic or single-gene (Sanger) sequencing
Speed (TAT)	8 weeks (comprehensive bioinformatics included)	2–4 weeks for culture; 1–2 weeks for Sanger (limited scope)

Physician Insight & Safety Protocols

"Advanced microbiome profiling through 16S rRNA sequencing offers a powerful lens into the bacterial communities that may influence a patient's clinical presentation. The V3-V4 region provides optimal taxonomic resolution, but results must always be interpreted alongside complete clinical history, physical examination findings, and conventional laboratory markers. This test is a complement to, not a replacement for, established diagnostic workflows."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory Notice

Patients are advised not to alter or discontinue any prescribed medications without prior consultation with their treating physician. This molecular test provides taxonomic data intended to inform clinical decision-making and does not replace a comprehensive medical evaluation or emergency care.

Exclusion Criteria & Emergency Red Flags

Active systemic infection requiring immediate antimicrobial therapy.
Recent (less than 2 weeks) antibiotic or probiotic use may distort microbial profile interpretation.
Severe immunocompromised state where sequencing may yield ambiguous clinical utility.
Seek emergency care if you experience: high fever (>38.5°C), severe abdominal pain, or signs of sepsis.

Patient FAQ & Clinical Guidance

1. What exactly does this test measure?

This advanced test sequences variable regions V3 and V4 of the 16S ribosomal RNA gene to identify and quantify bacteria in your sample, providing a comprehensive gut or systemic microbiome profile with species-level data for clinical correlation.

2. How should I prepare for the sample collection?

Avoid antibiotics and probiotics for at least two weeks before collection. A trained phlebotomist will draw whole blood or accept your previously extracted DNA following strict cold-chain protocols. VIP Mobile Phlebotomy and home collection are available daily from 8 AM to 11 PM.

3. Who interprets the results and how will I receive them?

A Consultant Medical Genetics specialist provides telephonic post-test guidance, explaining the taxonomic report and its potential link to your symptoms. Results are delivered securely through our online patient portal within 8 weeks of sample receipt.

4. Is insurance coverage available for this test?

Insurance coverage varies by policy. Our team can verify your direct billing eligibility via WhatsApp at +971 54 548 8731. Please have your insurance card and policy number ready for verification.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare regulations. All patient genomic and clinical data is processed, stored, and transmitted under the following legal frameworks:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal health information.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health data exchange and telemedicine consultation protocols.
Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring all clinical testing, patient consent, and safety procedures meet statutory medical accountability standards.

Our DHA-licensed facility adheres to strict confidentiality agreements, encrypted data transmission, and role-based access controls for all diagnostic records.

Clinical & Logistical Metadata

Test Name	Bacterial 16S rRNA V3-V4 Amplicon Sequencing & Analysis
Price (AED)	1,500
Turnaround Time	8 Weeks
Sample Type / Matrix	Whole Blood or Extracted DNA (Archival Tissue Accepted via Secure Medical Courier Solid Tissue Specimen Retrieval)
Methodology Used	Illumina MiSeq Next-Generation Sequencing (PE300 Chemistry)
ICD-10-CM Code	B96.89, Z22.8
LOINC Code	92727-3
DHA Facility License & Address	DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE